LT - COMPOSITIONS OF AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY
EN - COMPOSITIONS OF AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
A61K 31/4245 |
|
|
|
A61P 3/10 |
|
|
|
A61P 7/00 |
|
|
|
A61P 9/00 |
|
|
|
A61P 11/00 |
|
|
|
A61P 25/00 |
|
|
|
A61P 25/28 |
|
|
|
A61P 35/00 |
|
European patent
(11) |
Number of the document |
1874306 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
06749439.3 |
|
Date of filing the European patent application |
2006-04-06 |
(97) |
Date of publication of the European application |
2008-01-09 |
(45) |
Date of publication and mention of the grant of the patent |
2012-07-04
|
(46) |
Date of publication of the claims translation |
|
PCT application
(86) |
Number |
PCT/US2006/012887 |
|
Date |
2006-04-06 |
PCT application publication
(87) |
Number |
WO 2006/110483 |
|
Date |
2006-10-19 |
Priority applications
(30) |
Number |
Date |
Country code |
|
669789 P |
2005-04-08
|
US |
|
787395 P |
2006-03-30
|
US |
Inventors
(72) |
HIRAWAT, Samit, US
MILLER, Langdon, US
|
Grantee
(73) |
PTC Therapeutics, Inc.,
100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080,
US
|
Title
(54) |
COMPOSITIONS OF AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY |
|
COMPOSITIONS OF AN ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSION THERAPY |